This Multibagger Pharma Stock Secures Strategic Foothold in Europe — Is It Set for Massive Growth? This Multibagger Pharma Stock Secures Strategic Foothold in Europe — Is It Set for Massive Growth? Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue Streams DSIJ Intelligence / Wednesday, November 6, 2024 / Article rating: 3.8 Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue Streams
Vijay Kedia & Mukul Agrawal’s Portfolio Multibagger Pharma Stock Falls Over 14 Per Cent In Past 1 Hour; Here’s Why Vijay Kedia & Mukul Agrawal’s Portfolio Multibagger Pharma Stock Falls Over 14 Per Cent In Past 1 Hour; Here’s Why The company has a market cap of over Rs 17,000 crore with a PE of 55x, an ROE of 27 per cent and an ROCE of 33 per cent. DSIJ Intelligence / Wednesday, November 6, 2024 / Article rating: 4.5 The stock gave multibagger returns of 250 per cent in 1 year, 720 per cent in 3 years and a whopping 2,700 per cent in 5 years.
Multibagger Pharma Stock Hit 52-Week High As Board Announces Stock Split From Rs 5 to Rs 2 and Stellar Quarterly Results (Q2FY25) and Half-Yearly Results (H1FY25) Multibagger Pharma Stock Hit 52-Week High As Board Announces Stock Split From Rs 5 to Rs 2 and Stellar Quarterly Results (Q2FY25) and Half-Yearly Results (H1FY25) The stock is up by 85 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of 1,895 per cent in 5 years. DSIJ Intelligence / Thursday, October 24, 2024 / Article rating: 3.9 The stock is up by 85 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of 1,895 per cent in 5 years.
Multibagger Pharma Stock To Keep Under Radar As Board Likely To Announce Stock Split Multibagger Pharma Stock To Keep Under Radar As Board Likely To Announce Stock Split The stock is up by 75 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of over 1,800 per cent in 5 years. DSIJ Intelligence / Sunday, October 20, 2024 / Article rating: 4.1 The stock is up by 75 per cent from its 52-week low of Rs 270.05 per share and gave multibagger returns of over 1,800 per cent in 5 years.
Pharma Penny Stock At Rs 65 Enters Into An Mou With Vaibhav Kashinath Chaudhari & Mistycube Analytics To Enter French West African Market Pharma Penny Stock At Rs 65 Enters Into An Mou With Vaibhav Kashinath Chaudhari & Mistycube Analytics To Enter French West African Market The company has a market cap of Rs 76 crore and as of September 27, 2024, the stock is trading at Rs 65 per share on NSE. DSIJ Intelligence / Sunday, September 29, 2024 / Article rating: 4.3 The company has a market cap of Rs 76 crore and as of September 27, 2024, the stock is trading at Rs 65 per share on NSE.
Multibagger Pharma Company Recommends 1:1 Bonus Issue and 1:5 Stock Split; Expects to Continue its Strong Growth Momentum with Innovation Multibagger Pharma Company Recommends 1:1 Bonus Issue and 1:5 Stock Split; Expects to Continue its Strong Growth Momentum with Innovation In July 2024, the promoters of the company bought 13,02,000 shares and increased their stake to 31.61 per cent compared to 26.32 per cent in June 2024. DSIJ Intelligence / Sunday, September 1, 2024 / Article rating: 4.3 From Rs 38.05 to Rs 187.25 per share, the stock gave multibagger returns of 393 per cent in 3 years.
Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split! Pharma stock under Rs 65 is in the green as Board allots 52,52,190 equity shares to non-promoters post-stock split! From Rs 35.03 per share (52-week low) to Rs 60.09 per share, the stock is up by 71.5 per cent and gave multibagger returns of 110 per cent in 2 years. DSIJ Intelligence / Friday, August 30, 2024 / Article rating: 4.6 From Rs 35.03 per share (52-week low) to Rs 60.09 per share, the stock is up by 71.5 per cent and gave multibagger returns of 110 per cent in 2 years.
Multibagger pharma stock under Rs 70 to keep under the radar as company announces positive quarterly results (Q1FY25) Multibagger pharma stock under Rs 70 to keep under the radar as company announces positive quarterly results (Q1FY25) From Rs 33.30 per share (52-week low) to Rs 63.79 per share, the stock is up by 91.6 per cent and gave multibagger returns of 156 per cent in 2 years. DSIJ Intelligence / Wednesday, August 7, 2024 / Article rating: 3.7 From Rs 33.30 per share (52-week low) to Rs 63.79 per share, the stock is up by 91.6 per cent and gave multibagger returns of 156 per cent in 2 years.
Stock at Rs 130.05 from the pharmaceuticals industry hit upper circuit as Board announces 1:1 bonus share; Record date inside! Stock at Rs 130.05 from the pharmaceuticals industry hit upper circuit as Board announces 1:1 bonus share; Record date inside! The company has a market cap of Rs 51.55 crore and stock is up by 66 per cent from its 52-week low of Rs 78 per share. DSIJ Intelligence / Sunday, August 4, 2024 / Article rating: 3.6 The company has a market cap of Rs 51.55 crore and stock is up by 66 per cent from its 52-week low of Rs 78 per share.
Bonus Alert: 1 share par 3 free shares after 8 days & Company bags order worth Rs 175 crore from UK; Multibagger pharma products stock to watch out! Bonus Alert: 1 share par 3 free shares after 8 days & Company bags order worth Rs 175 crore from UK; Multibagger pharma products stock to watch out! The company's shares have an ROE of 123 per cent and an ROCE of 100 per cent. DSIJ Intelligence / Thursday, June 27, 2024 / Article rating: 4.1 The stock gave multibagger returns of 1,600 per cent in 3 years and a whopping 8,675 per cent in 5 years.